Clinical Research Directory
Browse clinical research sites, groups, and studies.
APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study
Sponsor: APrevent Biotech GmbH
Summary
This is a prospective, 2-part, multi-center, open-label, non-randomized clinical trial to assess safety and effectiveness of APrevent® VOIS Implants for the treatment of patients with Unilateral Vocal Fold Paralysis (UVFP). In total 30 evaluable patients are planned to be enrolled.
Official title: Study on the Safety and Effectiveness of APrevent® VOIS Implants for Treatment in Patients With Unilateral Vocal Fold Paralysis (UVFP) - a Two-Part, Open-Label, Non-Randomized Multicenter Study
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2019-11-13
Completion Date
2026-09
Last Updated
2025-02-06
Healthy Volunteers
Yes
Conditions
Interventions
APrevent® VOIS-Implant
To compare the voice quality assessed by the change in G-Score from GRBAS-Scale between before and after permanent APrevent® VOIS implantation.
Locations (7)
Mayo Clinic - Phoenix
Phoenix, Arizona, United States
Greater Baltimore Medical Center
Baltimore, Maryland, United States
Cleveland Clinic
Cleveland, Ohio, United States
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Medical University of Vienna
Vienna, Austria
SRH Wald-Klinikum Gera
Gera, Germany
University Medical Center
Hamburg, Germany